Personalis Cash Conversion Cycle 2011-2026 | PSNL

Annual Cash Conversion Cycle Personalis

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-11.5	-6.34	20.6	-6.42	-26.4	-31.6	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
20.6	-31.6	-10.3

Quarterly Cash Conversion Cycle Personalis

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
0.16	-9.89	-6.41	-	-13.4	-10.9	-10.4	-	4.47	1.37	7.26	-	1.99	-6.3	6.27	-	-11.5	-15.7	-18.8	-	-23.1	-21.4	-24.2	16.6	-40.5	-48.4	-37.7	30.9	-48.6	-23.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
30.9	-48.6	-12.1

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
Agilent Technologies A	111	$ 118.37	-1.17 %	$ 36 B	USA
Burning Rock Biotech Limited BNR	149	$ 19.58	-4.79 %	$ 211 M	China
Aspira Women's Health AWH	1.01 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Medpace Holdings MEDP	50.4	$ 520.39	0.36 %	$ 15 B	USA
CareDx, Inc CDNA	51.5	$ 21.48	22.25 %	$ 1.14 B	USA
NeoGenomics NEO	82.4	$ 8.39	-3.34 %	$ 1.07 B	USA
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Koninklijke Philips N.V. PHG	89	$ 29.06	-0.1 %	$ 20 B	Niderland
Exact Sciences Corporation EXAS	42.5	-	-	$ 19.8 B	USA
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	-2.46 K	$ 1.41	-0.69 %	$ 1.88 M	USA
Castle Biosciences CSTL	45.9	$ 24.39	-0.93 %	$ 677 M	USA
Senseonics Holdings SENS	36.1	$ 6.77	-1.88 %	$ 282 M	USA
Soleno Therapeutics SLNO	-398	$ 52.62	0.09 %	$ 2.67 B	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Neuronetics STIM	17.3	$ 1.35	-2.87 %	$ 89 M	USA
Charles River Laboratories International CRL	65	$ 181.2	0.35 %	$ 8.98 B	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Thermo Fisher Scientific TMO	70	$ 524.15	-1.41 %	$ 198 B	USA
Danaher Corporation DHR	77.5	$ 194.8	-1.69 %	$ 139 B	USA
Interpace Biosciences IDXG	62.9	$ 1.95	-11.36 %	$ 8.63 M	USA
Trinity Biotech plc TRIB	136	$ 0.7	-0.83 %	$ 61.9 M	Irlanda
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
Twist Bioscience Corporation TWST	83.6	$ 56.37	-2.17 %	$ 3.37 B	USA
Illumina ILMN	142	$ 130.3	-1.48 %	$ 20.7 B	USA
Fulgent Genetics FLGT	42.4	$ 15.95	-1.36 %	$ 482 M	USA
Guardant Health GH	79.6	$ 84.69	-0.21 %	$ 10.6 B	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	275	$ 2.82	-3.75 %	$ 91.5 K	USA
Biomerica BMRA	172	$ 2.19	3.79 %	$ 5.03 M	USA
Waters Corporation WAT	731	$ 321.93	-1.31 %	$ 19.2 B	USA
ICON Public Limited Company ICLR	62	$ 116.76	0.22 %	$ 9.63 B	Irlanda
Laboratory Corporation of America Holdings LH	40.3	$ 268.36	0.61 %	$ 22.3 B	USA
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Myriad Genetics MYGN	49.3	$ 5.16	-0.67 %	$ 478 M	USA
Lantheus Holdings LNTH	97.3	$ 83.68	-0.31 %	$ 5.65 B	USA
Neogen Corporation NEOG	150	$ 9.26	-1.7 %	$ 2.01 B	USA
Quest Diagnostics Incorporated DGX	39.5	$ 193.65	1.16 %	$ 21.5 B	USA